Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
20 studies found for:    Open Studies | "Hyperpigmentation"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hyperpigmentation"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting An In Vivo Model for Postinflammatory Hyperpigmentation
Condition: Post-inflammatory Hyperpigmentation
Intervention: Drug: Tricholoacetic Acid (TCA)
2 Not yet recruiting Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid
Condition: Melasma
Interventions: Drug: Modified Jessner's solution;   Drug: Glycolic acid;   Drug: Trichloroacetic acid
3 Not yet recruiting 1064-nm Q-switched Nd:YAG Laser and Intradermal Tranexamic Acid for Melasma
Condition: Melasma
Interventions: Procedure: intradermal tranexamic acid;   Device: Nd-YAG
4 Recruiting Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Subjects With Moderate Facial Melasma
Condition: Melasma
Interventions: Other: Lytera 2.0;   Other: 4% Hydroquinone Topical Cream
5 Not yet recruiting Tri-split Face Study of Skin Resurfacing Modalities for the Treatment of Melasma
Condition: Melasma
Interventions: Drug: 22% TCA peel;   Device: CO2 laser;   Device: Qs-NdYag laser
6 Not yet recruiting Treatment of Melasma With Glycolic Acid-Salicylic Acid Peel Versus Glycolic Acid Peel
Condition: Melasma
Interventions: Drug: Glycolic acid peel alone;   Drug: Glycolic and salicylic acid peel
7 Recruiting Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma
Condition: Melasma
Intervention: Drug: Illuminate Cream
8 Not yet recruiting Clinical Evaluation of the Performance of a Difluoroethane-based Cyto-selective Cryotherapy to Treat Dark Spots on the Hand in 30 Volunteers.
Condition: Solar Lentigo
Intervention: Device: CRYOBEAUTY MAINS
9 Recruiting Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukaemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
Intervention:
10 Recruiting Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer
Conditions: Stomach Neoplasms;   Stomach Cancer;   Familial Cancer;   Fundic Gland Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   Peutz-Jeghers Syndrome
Intervention:
11 Recruiting Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face
Condition: Lentigo Maligna
Intervention: Drug: Picato gel
12 Recruiting Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream
Condition: Lentigo Maligna
Intervention: Drug: 5-aminolevulinic acid nanoemulsion
13 Not yet recruiting Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes
Conditions: Noonan Syndrome;   LEOPARD Syndrome
Intervention:
14 Recruiting Radiotherapy or Imiquimod in Complex Lentigo Maligna
Condition: Lentigo Maligna
Interventions: Drug: Imiquimod;   Radiation: Radiotherapy
15 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
16 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome (PJS);   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
17 Recruiting Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Condition: Lentigo Maligna Melanoma (Head or Neck)
Interventions: Drug: Imiquimod cream + surgery;   Drug: vehicle + surgery
18 Recruiting Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
Condition: Lentigo Maligna
Intervention: Drug: Imiquimod
19 Recruiting Hereditary Colorectal and Associated Tumor Registry Study
Conditions: Lynch Syndrome;   FAP;   Hereditary Diffuse Gastric Cancer;   Juvenile Polyposis Syndrome;   Peutz-Jeghers Syndrome
Intervention: Other: Research Registry
20 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:

Study has passed its completion date and status has not been verified in more than two years.